مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.
Normal view MARC view ISBD view

Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience. [electronic resource]

By:
  • Beköz, H
Contributor(s):
  • Karadurmuş, N
  • Paydaş, S
  • Türker, A
  • Toptaş, T
  • Fıratlı Tuğlular, T
  • Sönmez, M
  • Gülbaş, Z
  • Tekgündüz, E
  • Kaya, A H
  • Özbalak, M
  • Taştemir, N
  • Kaynar, L
  • Yıldırım, R
  • Karadoğan, I
  • Arat, M
  • Pepedil Tanrıkulu, F
  • Özkocaman, V
  • Abalı, H
  • Turgut, M
  • Kurt Yüksel, M
  • Özcan, M
  • Doğu, M H
  • Kabukçu Hacıoğlu, S
  • Barışta, I
  • Demirkaya, M
  • Köseoğlu, F D
  • Toprak, S K
  • Yılmaz, M
  • Demirkürek, H C
  • Demirkol, O
  • Ferhanoğlu, B
Producer: 20180529Description: 2496-2502 p. digitalISSN:
  • 1569-8041
Subject(s):
  • Adolescent
  • Adult
  • Aged
  • Antibodies, Monoclonal -- therapeutic use
  • Antineoplastic Agents -- therapeutic use
  • Brentuximab Vedotin
  • Disease-Free Survival
  • Female
  • Hodgkin Disease -- drug therapy
  • Humans
  • Immunoconjugates -- therapeutic use
  • Male
  • Middle Aged
  • Nivolumab
  • Retrospective Studies
  • Stem Cell Transplantation
  • Young Adult
Online resources:
  • Available from publisher's website
In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article; Multicenter Study

There are no comments on this title.

Log in to your account to post a comment.

Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.

APA

Beköz H., Karadurmuş N., Paydaş S., Türker A., Toptaş T., Fıratlı Tuğlular T., Sönmez M., Gülbaş Z., Tekgündüz E., Kaya A. H., Özbalak M., Taştemir N., Kaynar L., Yıldırım R., Karadoğan I., Arat M., Pepedil Tanrıkulu F., Özkocaman V., Abalı H., Turgut M., Kurt Yüksel M., Özcan M., Doğu M. H., Kabukçu Hacıoğlu S., Barışta I., Demirkaya M., Köseoğlu F. D., Toprak S. K., Yılmaz M., Demirkürek H. C., Demirkol O. & Ferhanoğlu B. (20180529). Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Beköz H, Karadurmuş N, Paydaş S, Türker A, Toptaş T, Fıratlı Tuğlular T, Sönmez M, Gülbaş Z, Tekgündüz E, Kaya A H, Özbalak M, Taştemir N, Kaynar L, Yıldırım R, Karadoğan I, Arat M, Pepedil Tanrıkulu F, Özkocaman V, Abalı H, Turgut M, Kurt Yüksel M, Özcan M, Doğu M H, Kabukçu Hacıoğlu S, Barışta I, Demirkaya M, Köseoğlu F D, Toprak S K, Yılmaz M, Demirkürek H C, Demirkol O and Ferhanoğlu B. 20180529. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Beköz H., Karadurmuş N., Paydaş S., Türker A., Toptaş T., Fıratlı Tuğlular T., Sönmez M., Gülbaş Z., Tekgündüz E., Kaya A. H., Özbalak M., Taştemir N., Kaynar L., Yıldırım R., Karadoğan I., Arat M., Pepedil Tanrıkulu F., Özkocaman V., Abalı H., Turgut M., Kurt Yüksel M., Özcan M., Doğu M. H., Kabukçu Hacıoğlu S., Barışta I., Demirkaya M., Köseoğlu F. D., Toprak S. K., Yılmaz M., Demirkürek H. C., Demirkol O. and Ferhanoğlu B. (20180529). Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Beköz H, Karadurmuş N, Paydaş S, Türker A, Toptaş T, Fıratlı Tuğlular T, Sönmez M, Gülbaş Z, Tekgündüz E, Kaya A H, Özbalak M, Taştemir N, Kaynar L, Yıldırım R, Karadoğan I, Arat M, Pepedil Tanrıkulu F, Özkocaman V, Abalı H, Turgut M, Kurt Yüksel M, Özcan M, Doğu M H, Kabukçu Hacıoğlu S, Barışta I, Demirkaya M, Köseoğlu F D, Toprak S K, Yılmaz M, Demirkürek H C, Demirkol O and Ferhanoğlu B. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience. : Annals of oncology : official journal of the European Society for Medical Oncology. 20180529.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site